Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Jenny C. Chang"'
Autor:
Tasneem Bawa-Khalfe, Prasenjit Dey, Akanksha Verma, Olivier Elemento, Jan-Åke Gustafsson, Anders Ström, Dong S. Choi, Samaneh Karami, Michelle Faria, Jenny C. Chang, Sergio Granados-Principal
Publikováno v:
Oncotarget
// Michelle Faria 1 , Samaneh Karami 1 , Sergio Granados-Principal 2 , Prasenjit Dey 3, 4 , Akanksha Verma 5 , Dong S. Choi 6 , Olivier Elemento 5 , Tasneem Bawa-Khalfe 1 , Jenny C. Chang 6 , Anders M. Strom 1 and Jan-Ake Gustafsson 1, 7 1 University
Autor:
Jenny C. Chang, Jianting Sheng, Jiyong Liu, Hong Zhao, Zhen Zhao, Kemi Cui, Jiang Wang, Jing Zhong, Xiaoping Zhu, Stephen T. C. Wong
Publikováno v:
Oncotarget
Interactions among tumor cells, stromal cells, and extracellular matrix compositions are mediated through cytokines during tumor progression. Our analysis of 132 known cytokines and growth factors in published clinical breast cohorts and our 84 patie
Autor:
Leandro Cerchietti, Dong Soon Choi, Warren Fiskus, Ari Melnick, Scott W. Hiebert, Bhavin Shah, Sunil Sharma, Kapil N. Bhalla, Kyungsoo Ha, Jenny C. Chang, Srividya Bhaskara, Santhana G. T. Devaraj
Publikováno v:
Scopus-Elsevier
Oncotarget
Oncotarget
There is an unmet need to develop new, more effective and safe therapies for the aggressive forms of triple negative breast cancers (TNBCs). While up to 20% of women under 50 years of age with TNBC harbor germline mutations in BRCA1, and these tumors
Autor:
Ruth A. Keri, Cheryl L. Thompson, Jenny C. Chang, Chevaun D. Morrison, William P. Schiemann, Tressa M. Allington, Hannah Gilmore
Publikováno v:
Oncotarget
We previously reported that constitutive c-Abl activity (CST-Abl) abrogates the tumorigenicity of triple-negative breast cancer cells through the combined actions of two cellular events: downregulated matrix metalloproteinase (MMP) and upregulated p2